Gynecologic Oncology
Expert gynecological cancer care.
Reclaim your life.
Gynecologic oncology focuses on the diagnosis and treatment of cancers that affect the female reproductive system. At St. Luke's University Health Network, we understand that a cancer diagnosis can be overwhelming. Our dedicated team of board-certified gynecologic oncologists, part of the comprehensive St. Luke’s Cancer Center, provide advanced, compassionate care for women facing these challenging conditions. We are committed to offering innovative treatments and personalized support to help you reclaim your life.
Understanding gynecologic cancers
Gynecologic cancers are a group of cancers that originate in the female reproductive organs. Several types exist, each with unique characteristics and treatment approaches. These include cervical cancer (affects the cervix), ovarian cancer (originates in the ovaries), uterine (endometrial) cancer (begins in the uterus), vaginal cancer (rare cancer that forms in the vagina), and vulvar cancer (rare cancer that forms on the outer surface of the female genitalia). Early detection and accurate diagnosis are crucial for effective treatment. Our team utilizes state-of-the-art diagnostic tools and collaborates closely to ensure a precise understanding of your condition.
Comprehensive and innovative treatment approaches
St. Luke’s Gynecologic Oncology offers a multidisciplinary approach to cancer care, integrating surgical and medical management to provide the most effective treatment plan for each patient. Our board-certified gynecologic oncologists are experts in the surgical and medical management of these complex cancers. Patients have access to a wide range of innovative cancer treatments, including:
- Surgery: Often the primary treatment for many gynecologic cancers, performed by highly skilled gynecologic oncologists.
- Radiation therapy: Utilizing advanced techniques to target cancer cells while sparing healthy tissue.
- Chemotherapy: Systemic treatments designed to destroy cancer cells throughout the body.
- Hormonal therapies: Used for hormone-sensitive cancers to block hormone production or action.
- Targeted therapies: Medications that specifically target cancer cells based on their genetic makeup.
- Immunotherapy: Treatments that boost the body's natural defenses to fight cancer.
- Investigational protocols: Offering access to the very latest advancements in cancer care, providing opportunities for patients to receive new treatments before they are widely available. St. Luke’s participates in studies sponsored by the National Cancer Institute through groups such as the Eastern Cooperative Oncology Group, the Radiation Therapy Oncology Group, the Gynecological Oncology Group, and the American College of Surgeons Oncology Group, as well as many other national and international studies.
Our services are coordinated before, during, and after treatment to ensure a seamless continuum of care, providing support and guidance every step of the way.
Clinical trials
Clinical trials offer patients access to the very latest in cancer care, while giving physicians and researchers the opportunity to study the effectiveness of new treatments.
The Cancer Network participates in studies sponsored by the National Cancer Institute through groups such as the Eastern Cooperative Oncology Group, the Radiation Therapy Oncology Group, the Gynecological Oncology Group and the American College of Surgeons Oncology Group. In addition, St. Luke’s participates in many other national and international cancer studies sponsored by the pharmaceutical industry.
St. Luke’s earns prestigious recognition from the Commission on Cancer
St. Luke’s University Health Network has earned national Three-Year Accreditation with Commendation as an Integrated Network Cancer Program (INCP) from the Commission on Cancer of the American College of Surgeons (CoC). St. Luke’s is one of only two health care networks in Pennsylvania to receive this distinction, and one of only 51 health care networks nationwide. Our recent Commission on Cancer of the American College of Surgeons distinction followed a rigorous survey.
Frequently asked questions about gynecological oncology
Gynecologic oncology is a specialized field of medicine that focuses on the diagnosis, treatment, and prevention of cancers of the female reproductive system, including ovarian, uterine, cervical, vaginal, and vulvar cancers.
St. Luke's treats all types of gynecologic cancers, including cervical, ovarian, uterine (endometrial), vaginal, and vulvar cancers. Our team is equipped to handle both common and rare forms of these diseases.
Symptoms can vary depending on the type of cancer but may include abnormal vaginal bleeding or discharge, pelvic pain or pressure, abdominal bloating, changes in bowel or bladder habits, and unexplained weight loss. It's important to discuss any persistent or unusual symptoms with your doctor.
Yes, St. Luke's actively participates in numerous national and international clinical trials, offering patients access to the latest investigational treatments and therapies for gynecologic cancers.
Diagnosis typically involves a combination of physical exams, imaging tests (such as ultrasound, CT, MRI), blood tests, and biopsies. Our multidisciplinary team works quickly to provide an accurate diagnosis and develop a personalized treatment plan.
Your health matters: find the right gynecologist.
If you or a loved one has been diagnosed with a gynecologic cancer, contact St. Luke’s University Health Network to schedule a consultation with one of our expert gynecologic oncologists. Call 484-526-8600 or visit our online physician finder to connect with a specialist dedicated to your care.